Syncom Formulations is trading 5.57% up now at ₹21.40, with no clearly verified September 8, 2026 catalyst identified.
- A September 7 announcement outlined the September 30 AGM, proposed appointments, and a ₹0.10 FY26 dividend, but the source does not explicitly connect it to the price movement.
- Trading is closed and volume or activity data is unavailable; the reason remains unconfirmed.